Independent Pharmacy Funding — Inventory, Reimbursement-Gap & Growth Capital

Independent pharmacy funding addresses a cash-flow problem the chains can absorb but independents feel sharply: drug inventory — especially expensive brand and specialty medications — must be bought up front, while PBM and insurance reimbursements lag and are clawed back through DIR fees. Margins look thin and volatile even when prescription volume is strong. Y Millennial Funding provides revenue-based capital structured as a merchant cash advance — not a loan — for independent retail, compounding, specialty, and long-term-care pharmacies doing $25,000 or more in monthly revenue. We are a direct funder, not a broker, and we underwrite on your bank deposits and prescription revenue rather than credit score or hard collateral. Pharmacies use this capital to buy drug and specialty inventory, cover payroll and operating costs through reimbursement lags, upgrade pharmacy systems, renovate or relocate, acquire another pharmacy or patient file, and expand into compounding or clinical services. Because remittance is a percentage of revenue, it flexes with collections, and approval is fast enough to stock inventory or close an acquisition. A merchant cash advance is the purchase of future receivables, not a loan. Not all applicants qualify, and approval depends on revenue patterns, deposit consistency, time in business, and other factors.